Achmea Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $836K | Hold |
3,822
| – | – | 0.01% | 315 |
|
|
2025
Q1 | $856K | Buy |
3,822
+1,113
| +41% | +$249K | 0.01% | 338 |
|
|
2024
Q4 | $887K | Sell |
2,709
-1,945
| -42% | -$637K | 0.01% | 364 |
|
|
2024
Q3 | $1.4M | Sell |
4,654
-2,602
| -36% | -$781K | 0.02% | 339 |
|
|
2024
Q2 | $2.39M | Sell |
7,256
-3,804
| -34% | -$1.25M | 0.04% | 299 |
|
|
2024
Q1 | $4.38M | Hold |
11,060
| – | – | 0.08% | 236 |
|
|
2023
Q4 | $3.9M | Sell |
11,060
-326
| -3% | -$115K | 0.08% | 245 |
|
|
2023
Q3 | $4.27M | Buy |
11,386
+3,824
| +51% | +$1.43M | 0.09% | 227 |
|
|
2023
Q2 | $2.89M | Buy |
7,562
+4,300
| +132% | +$1.64M | 0.06% | 300 |
|
|
2023
Q1 | $1.13M | Hold |
3,262
| – | – | 0.03% | 379 |
|
|
2022
Q4 | $719K | Sell |
3,262
-2,698
| -45% | -$595K | 0.02% | 442 |
|
|
2022
Q3 | $1.47M | Sell |
5,960
-4,433
| -43% | -$1.09M | 0.05% | 328 |
|
|
2022
Q2 | $3.14M | Sell |
10,393
-7,036
| -40% | -$2.13M | 0.1% | 222 |
|
|
2022
Q1 | $7.16M | Buy |
+17,429
| New | +$7.16M | 0.19% | 127 |
|
|
2021
Q4 | – | Sell |
-30,231
| Closed | -$12.8M | – | 669 |
|
|
2021
Q3 | $12.8M | Sell |
30,231
-193
| -0.6% | -$81.9K | 0.39% | 51 |
|
|
2021
Q2 | $10.9M | Buy |
30,424
+879
| +3% | +$316K | 0.37% | 56 |
|
|
2021
Q1 | $8.33M | Sell |
29,545
-1,610
| -5% | -$454K | 0.29% | 93 |
|
|
2020
Q4 | $8.83M | Buy |
31,155
+2,706
| +10% | +$767K | 0.32% | 79 |
|
|
2020
Q3 | $7.82M | Buy |
+28,449
| New | +$7.82M | 0.33% | 79 |
|